The tumor microenvironment in colorectal carcinogenesis
- PMID: 21209781
- PMCID: PMC2990487
- DOI: 10.1007/s12307-010-0038-3
The tumor microenvironment in colorectal carcinogenesis
Abstract
Colorectal cancer is the second leading cause of cancer-related mortality in the United States. Therapeutic developments in the past decade have extended life expectancy in patients with metastatic disease. However, metastatic colorectal cancers remain incurable. Numerous agents that were demonstrated to have significant antitumor activity in experimental models translated into disappointing results in extending patient survival. This has resulted in more attention being focused on the contribution of tumor microenvironment to the progression of a number of solid tumors including colorectal cancer. A more complete understanding of interactions between tumor epithelial cells and their stromal elements will enhance therapeutic options and improve clinical outcome. Here we will review the role of various stromal components in colorectal carcinogenesis and discuss the potential of targeting these components for the development of future therapeutic agents.
Keywords: Colon cancer; Extracellular matrix; Stroma; Tumor infiltrating cells; Tumor microenvironment.
Figures
Similar articles
-
Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.J Urol. 2005 Jan;173(1):10-20. doi: 10.1097/01.ju.0000141582.15218.10. J Urol. 2005. PMID: 15592017 Review.
-
Epithelial-Stromal Interactions in Pancreatic Cancer.Annu Rev Physiol. 2019 Feb 10;81:211-233. doi: 10.1146/annurev-physiol-020518-114515. Epub 2018 Nov 12. Annu Rev Physiol. 2019. PMID: 30418798 Review.
-
Role of Tumor Specific niche in Colon Cancer Progression and Emerging Therapies by Targeting Tumor Microenvironment.Adv Exp Med Biol. 2021;1341:177-192. doi: 10.1007/5584_2019_355. Adv Exp Med Biol. 2021. PMID: 30969400 Review.
-
Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer.Clin Cancer Res. 2006 Mar 15;12(6):1876-82. doi: 10.1158/1078-0432.CCR-05-2686. Clin Cancer Res. 2006. PMID: 16551873
-
Tumor Microenvironment in Metastatic Colorectal Cancer: The Arbitrator in Patients' Outcome.Cancers (Basel). 2021 Mar 6;13(5):1130. doi: 10.3390/cancers13051130. Cancers (Basel). 2021. PMID: 33800796 Free PMC article. Review.
Cited by
-
Postoperative simple biochemical markers for prediction of bone metastases in Egyptian breast cancer patients.Ecancermedicalscience. 2013 Apr 15;7:305. doi: 10.3332/ecancer.2013.305. Print 2013. Ecancermedicalscience. 2013. PMID: 23653670 Free PMC article.
-
Mechanistic aspects of COX-2 expression in colorectal neoplasia.Recent Results Cancer Res. 2013;191:7-37. doi: 10.1007/978-3-642-30331-9_2. Recent Results Cancer Res. 2013. PMID: 22893198 Free PMC article. Review.
-
Tumor microsomal metabolism of the food toxicant, benzo(a)pyrene, in ApcMin mouse model of colon cancer.Tumour Biol. 2012 Aug;33(4):1255-60. doi: 10.1007/s13277-012-0375-6. Epub 2012 Mar 20. Tumour Biol. 2012. PMID: 22430258 Free PMC article.
-
Establishment of three novel cell lines derived from African American patients with colorectal carcinoma: A unique tool for assessing racial health disparity.Int J Oncol. 2018 Oct;53(4):1516-1528. doi: 10.3892/ijo.2018.4510. Epub 2018 Jul 31. Int J Oncol. 2018. PMID: 30066857 Free PMC article.
-
Newly Obtained Apple Pectin as an Adjunct to Irinotecan Therapy of Colorectal Cancer Reducing E. coli Adherence and β-Glucuronidase Activity.Cancers (Basel). 2021 Jun 12;13(12):2952. doi: 10.3390/cancers13122952. Cancers (Basel). 2021. PMID: 34204704 Free PMC article.
References
-
- Whitlock EP, Lin JS, Liles E, et al. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):638–658. - PubMed
-
- Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70. - PubMed
-
- Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature. 2008;454(7203):436–444. - PubMed
-
- Colotta F, Allavena P, Sica A, et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009;30(7):1073–1081. - PubMed
-
- DuBois RN, Giardiello FM, Smalley WE. Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention. Gastroenterol Clin North Am. 1996;25(4):773–791. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous